Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It could go either way, if they prove their success with one disease it could open a floodgate of other JVS throwing money at them hand over first to cure other diseases. I'll retain a very optimistic outlook until something leads me to believe otherwise.
The real deal resides in their patent for the process they use on treating diseases outside the body, it has many different applications so why would they limit themselves to only a few select diseases?? This is exciting
L2 is so thin, they can run this at anytime
Agreed, if I could tell the future I would invest in a 2$ powerball ticket
That really depends on the terms of the deal, if it's "really" good I can see an easy triple. What it will also do is solidify BIEI as a more legitimate company due to them no longer needing toxic financing and creating their own revenue. The real gem here is their secured patents to potentially cure cancer, I can't even fathom where this company will be in 5 years if it comes to fruition. We're talking beyond a 100SP. A 1,500$ investment could make someone a millionaire in 5 years; however, this is still OTC anything is possible. IMO the reward trumps the risk 10 fold, all I know is I'm grateful I stumbled upon this gem.
I was referencing the finalization of a JV, I'm not sure tbh. The terms of the financing are yet to be disclosed, are they going to provide them with a lump some of cash or finance the infrastructure to manufacture their drug or both? Time will tell
I'm pondering the upcoming PR and what it's going to entail, I know what I want to see... One thing I know is that the loan in itself has toxic terms but it will be paid off before any toxic things can ensue.
What leads you to believe tbsg
Background of some of the people who work at BIEI, Dr. Felders background is very impressive.
http://www.premierbiomedical.com/about/our-team/
There needs to be a binding LOI, and that's that. Everything else is noise, I'm sure there won't even be a LOI, just a PR stating a JV has been secured.
Check out BIEI for an easy triple, JV announcement is imminent
Just an FYI a LOI was in a October PR, is was non-binding but still a LOI nonetheless
Green on 450k volume... I'll take that all day, there is a lot of people whom have a close eye on this stock. JV approval is imminent and once finalized will send BIEI into the stratosphere!
Nice bid support just showed up, possible EOD run?
We could see a nice EOD finish here if the bids keep moving on up
Looking for a binding LOI, we all know non-binding doesn't mean anything
Don't recall where I said I want this under a penny? I just said it wouldn't matter, to me at least. I agree a LOI definitely wouldn't hurt, I still strongly believe Hartman has something up his sleeve, he hasn't been disingenuous thus far and claimed the funding is non-toxic for a reason. Time will tell all.
"Over" is far from the right terminology, this stock could drop to under a penny and it wouldn't matter. Watch what happens when a JV is finalized and redwood is paid off, the company will start making their own revenue, won't have to take on debt and further advance their flagship patent. I'm long either way, I'll snag up all the cheap shares I can, you're clearly not long. You're looking for a rise in PPS and you're own your way. Your posts tell a tall tale and clearly you're driven by emotion.
That's a gift? I got powder for anything under 2, locked and loaded.
Agreed, only 140k in volume?? Asinine, Gimmie that JV news and we will see a triple in price
Thin to 4 on l2, curious to see if that someone puts up the 700k ask
You're speaking my language
Not a chance, this blows past 8 with news of a JV because what comes along with that is paying off redwood which will make the company much more enticing to investors and a better BO candidate and will further expedite the introduction of their drug
Making moves baby, BIEI is such a gem. Hartman follows through again, no doubt in my mind this guy is the real deal and is dedicating himself fully to see that cancer be curable.
This will be a listing on the Nasdaq one day!
Silent in here.... what excites me the most is getting in at the right time. This company is on the verge of a busting out of its seems, I'm holding without a doubt, the people involved in this company whom are fighting for its success is a blessing to investors. There are brighter days ahead and believe I will be around to see them.
All it takes is news for this to have a couple hundred percent gain in day, I'm not worried one bit. Long and strong!
That powerball reference.. Lmao, hilarious
25k volume... So measley, I'm patiently waiting for that 25-40 million in volume. It's on the horizon!
Sounds like speculation to me, but let's talk about facts here. Hartman disclosed the loan as "non-toxic" you should really ponder about that. Hartman hasn't lied thus far and he clearly has no reason to, he's admitted his wrong doings and learns from his mistakes. He didn't take on more toxic funding because he knows how detrimental it would be for the company he wants to succeed. Keep in mind no one takes pay from the company, his intentions are pure and I'm going to stick around for quite sometime to reap the rewards.
The way the SP is currently sitting is a pretty picture, news of a JV will send this through the stratosphere.
Sellers are nowhere to be found, everyone is holding onto their shares.
Exactimundo, the patents, the technology and the team fueling BIEI is worth so much more than this current shit PPS. Im waiting for dollars, long and strong!!
Premier Biomedical, Inc. (OTCQB:BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as potential novel therapies for neurofibromatosis, atherosclerosis and muscular dystrophy, announced today they have obtained exclusive rights to the recently issued U.S. patent, "Sequential Extracorporeal Treatment of Bodily Fluids" (US Patent #9,216,386, 12/22/15), covering the basic technology underpinning Premier's on-going research into new, innovative treatments for many of today's most debilitating diseases. Premier Biomedical, Inc. intends to develop its proprietary methodology in which the pathologies are eradicated by sequentially dialyzing the patient's blood extracorporeally (outside the body). This extracorporeal methodology has an enormous potential for dramatically decreasing any side effects in the treatment of ill patients. The estimated expenditures for cancer treatment in the U.S. in 2010 were approx. $124.5 Billion, and projected to rise to $158 - $175 Billion by 2020(1). William A. Hartman, CEO and President of Premier Biomedical, stated that, "Between this sequential extracorporeal therapy patent just issued, and the previously granted patent "Utilization of Stents for the Treatment of Blood Borne Carcinomas" (US Patent #8,758,287: 6/24/14), I believe that we have a clear roadmap for potentially curing cancer, possibly at any stage, and even after extensive metastasis. These patents support our on-going experimentation and plans to present our stunning results to the American Association for Cancer Research (AACR) in April." Contact Premier via email at pr@premierbiomedical.com or by phone at (PBI) MED-7033 / (724) 633-7033. About Premier Biomedical, Inc. Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for a wide range of diseases in humans, initially targeting the treatment of cancer. The Company's common stock trades on the Over-The-Counter Bulletin Board under the ticker symbol "BIEI." http://www.premierbiomedicalinc.com/ Safe Harbor Notice Statements made in this news release constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Premier Biomedical makes no guarantee of future performance and actual results could differ materially. Premier Biomedical, Inc. undertakes no obligation to revise or update these. (1) Cancer costs projected to reach at least $158 billion in 2020; Posted: January 12, 2011, http://www.cancer.gov/news-events/press-releases/2011/costcancer2020 http://cts.businesswire.com/ct/CT?id=bwnews&sty=20160111005459r1&sid=cmtx6&distro=nx&lang=en View source version on businesswire.com: http://www.businesswire.com/news/home/20160111005459/en/ SOURCE: Premier Biomedical, Inc. Premier Biomedical, Inc. W. Hartman, 724-633-7033
Because only Hartman knows the truth, the money will be paid off via JV investment, just watch.
I wonder if NITE is going to pull his ask when it breaks 3, he has been stacking it the past few days
MM's taking advantage of uneducated investors and the current sentiment. Unfortunate situation to say the least but I remain long and strong, a partnership will be released within a 30 day time span and the 1.6 mill will be paid off. I have complete faith in BIEI and their future.
I don't know why everyone is so surprised, this stock ALWAYS drops in the morning, extremely volatile. Watch for a possible PR today and green EOD close. Irregardless of what happens I'm long and strong.
1.6 million is PENNIES!!! 6 mill from Brazil deal could be used to pay that off, or any investment from Europe, Asia, Africa, etc. Do yourself a favor and turn your computer off for 3 months.
today is a perfect opportunity to get cheap shares from people for two reasons.
1. Half a trading day
2. People not understanding the 8-k
I'll gladly hold my shares and not give a shit about the price today or next week for that matter. I'm an invester and a believer in the company. Invest in companies you want to own!! Long and strong